Thomas Burris, Ph.D., Saint Louis University (IMAGE)
Caption
Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University led a team of researchers in developing and testing a drug that suppresses lipogenesis, a key characteristic of NASH, in hopes of stopping its progression.
Credit
Saint Louis University
Usage Restrictions
None
License
Licensed content